X0306 4 2014-02-21 1 0001375200 NUPATHE INC. PATH 0001219866 ANIDO ARMANDO C/O NUPATHE INC., 7 GREAT VALLEY PARKWAY, SUITE 300 MALVERN PA 19355 1 1 0 0 Chief Executive Officer Common Stock 2014-02-21 4 D 0 1270000 6.80 D 0 D Includes all restricted stock units that became fully vested upon the consummation of the merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated January 17, 2014, among the issuer, Teva Pharmaceutical Industries Ltd. and Train Merger Sub, Inc. Disposed upon the consummation of the Merger in exchange for $3.65 per share, plus contractual rights to receive up to an additional $3.15 in contingent cash consideration payments per share. /s/ Michael F. Marino, attorney-in-fact 2014-02-25